+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

11th annual conference of the usa food and drug administration and drug law institute on food and drug contaminants and related problems arlington virginia usa november 27 1967 symposium microorganism drug quality



11th annual conference of the usa food and drug administration and drug law institute on food and drug contaminants and related problems arlington virginia usa november 27 1967 symposium microorganism drug quality



Medical Annals Of The District Of Columbia: 131




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 024179112

Download citation: RISBibTeXText


Related references

Food and Drug Administration Modernization Act of 1997; list of documents issued by the Food and Drug Administration that apply to medical devices regulated by the Center for Biologics Evaluation and Research. Food and Drug Administration, HHS. Notice. Federal Register 64(79): 20312-3, 1999

Food and Drug Administration Conference on the Kefauver-Harris Drug Amendments and related regulations, Washington, D C, USA, February, 1963. Jour New Drugs: 48-58, 1963

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. PharmacoTherapy 28(8): 992-998, 2008

Food and Drug Directorate, Department of National Health and Welfare: Symposium on drug safety, Ottawa, Ont., June 29-30, 1967. In Can Med Ass J 98(6): 271-321, 1968

Herb-drug, food-drug, nutrient-drug, and drug-drug interactions: mechanisms involved and their medical implications. Journal of Alternative and Complementary Medicine 8(3): 293-308, 2002

Remarks at the annual conference of the Food and Drug Law Institute. Food and Drug Law Journal 68(2): 217-223, 2014

Estimating the Impact of Food and Drug Administration's Unapproved Drug Initiative on Drug Prices and Sales. Therapeutic Innovation and Regulatory Science 2019: 2168479019839009, 2019

New drug applications; drug master files. Food and Drug Administration, HHS. Final rule. Federal Register 65(8): 1776-1780, 2000

Mechanisms and Clinical Significance of Pharmacokinetic-based Drug-drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017. Drug Metabolism and Disposition: the Biological Fate of Chemicals 2018, 2018

Association of food and drug officials food and drug administration model food salvage code an approach to the problem. Journal Of Food Protection: 913, 1985

Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016. Drug Metabolism and Disposition: the Biological Fate of Chemicals 46(6): 835-845, 2018

Methodological issues in AIDS clinical trials. A symposium sponsored by the National Institute of Allergy and Infectious Diseases and Food and Drug Administration. Bethesda, Maryland, November 20-21, 1989. Proceedings. Journal of Acquired Immune Deficiency Syndromes 3 Suppl 2: S1-147, 1990

Nonsteroidal anti-inflammatory drug-associated pulmonary infiltrates with eosinophilia. Review of the literature and Food and Drug Administration Adverse Drug Reaction reports. Archives of Internal Medicine 152(7): 1521-1524, 1992

Key Findings from Preclinical and Clinical Drug Interaction Studies Presented in New Drug and Biological License Applications Approved by the Food and Drug Administration in 2014. Drug Metabolism and Disposition: the Biological Fate of Chemicals 44(1): 83-101, 2016

Problems confronting the Food and Drug Administration in drug evaluation. Archives of Environmental Health 13(3): 307-311, 1966